Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
An Open-Label, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Induction with Melphalan/HDS Followed by Trifluridine?tipiracil plus Bevacizumab Versus Trifluridine?tipiracil plus Bevacizumab Alone in Patients with Refractory Metastatic Colorectal Cancer with Liver Dominant Disease
Study Type: Treatment
Phase: II
NCTID: NCT06607458
Principal Investigator:
Gregory Crane
Study of RMC-9805 with or without RMC-6236 in Combination with Cetuximab-based Therapies in Patients with RAS G12D-Mutant Unresectable or Metastatic Colorectal Cancer or Metastatic Pancreatic Ductal Adenocarcinoma ? Subprotocol E
Study Type: Treatment
Phase: I/II
NCTID: NCT06445062
Principal Investigator:
Raed Al-Rajabi
A Phase II Platform Study to Evaluate Treatment with Cemiplimab Monotherapy or Cemiplimab plus Fianlimab or Other Novel Combinations in Patients with Colorectal Cancer with Minimal Residual Disease Following Definitive Surgery and Chemotherapy EMPIRE
Study Type: Treatment
Phase: II
NCTID: NCT07058012
Principal Investigator:
Anup Kasi
Multi-site practice-based implementation of an colorectal screening intervention
Study Type: Health Services
Phase: N/A
NCTID: NCT06682650
Principal Investigator:
Joseph LeMaster
Reducing Neoplasia Recurrence After Endoscopic Resection Of Large Colorectal Polyps HAPC-RCT
Study Type: Treatment
Phase: N/A
NCTID: NCT06271941
Principal Investigator:
Amit Rastogi
Phase I Clinical Trial of CA-4948 Emavusertib in Combination with FOLFOX Plus Bevacizumab as Frontline Treatment in Patients with Metastatic Colorectal Cancer
Study Type: Treatment
Phase: I
NCTID: NCT06696768
Principal Investigator:
Raed Al-Rajabi